Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Liver|April 1, 1994
HBcAg and HBsAg expression in ductular cells in chronic hepatitis BJ K Delladetsima, I Vafiadis, N C Tassopoulos, et al.
The Journal of Pathology|January 1, 1995
Ductular structures in acute hepatitis with panacinar necrosisJ K Delladetsima, V Kyriakou, I Vafiadis, et al.
European Journal of Gastroenterology & Hepatology|March 26, 1998
Genotype distribution of hepatitis C virus infection in Greece: correlation with different risk factors and response to interferon therapyI Diamantis, I Vafiadis, E Voskaridou, et al.
Journal of Hepatology|January 1, 1996
Histopathology of chronic hepatitis C in relation to epidemiological factorsJ K Delladetsima, G Rassidakis, N C Tassopoulos, et al.
Gut|January 1, 1993
Hepatitis C virus infection among Greek renal transplant patientsI Vafiadis, J Boletis, H Papastathi, et al.
Hepato-Gastroenterology|January 30, 2002
The significance of the dosage adjustment of octreotide in the treatment of acute pancreatitis of moderate severityG C Nikou, T P Arnaoutis, E J Giamarellos-Bourboulis, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 16, 2007
Phase II study of gemcitabine plus 5-fluorouracil biologically modulated by folinic acid plus long-acting formulation of octreotide (LAR) in patients with advanced pancreatic cancerA Polyzos, N Tsavaris, I Vafiadis, et al.
Journal of Viral Hepatitis|September 13, 2003
A randomized trial to assess the efficacy of interferon-alpha daily in combination with ribavirin in the treatment of naïve patients with chronic hepatitis CN C Tassopoulos, I Ketikoglou, D Tsantoulas, et al.
Journal of Viral Hepatitis|July 3, 2004
Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infectionV Sypsa, G Touloumi, N C Tassopoulos, et al.
Journal of Viral Hepatitis|August 20, 2005
Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatmentsV Sypsa, G Touloumi, G V Papatheodoridis, et al.
Pageof 2